Pharmicell (005690.KS) Earnings Analysis
Pharmicell (005690.KS) next reports earnings on 2026-08-19, consensus EPS 213 KRW. Last quarter (2026-02-09) it beat with EPS 262 KRW vs 262 KRW est (0%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 15.40.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 005690.KS next report earnings?
| Next earnings date | 2026-08-19 |
|---|---|
| Consensus EPS estimate | 213 KRW |
| Revenue estimate | 42.10B |
005690.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-09 | 262 KRW | 262 KRW | 0% | Beat |
| 2025-08-11 | 123 KRW | n/a | n/a | n/a |
| 2025-02-10 | 69.23 KRW | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
005690.KS valuation and analyst view
| Trailing P/E | 15.40 |
|---|---|
| Trailing EPS | 726.29 KRW |
| Price / book | 5.05 |
| Dividend yield | 0.45% |
| Market cap | 643.24B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Pharmicell (005690.KS)'s next earnings date?
Pharmicell is next scheduled to report on 2026-08-19, with a consensus EPS estimate of 213 KRW and revenue estimate of 42.10B.
Did 005690.KS beat earnings last quarter?
In its 2026-02-09 report, 005690.KS posted EPS of 262 KRW versus a 262 KRW estimate — a beat of 0%.
What is 005690.KS's earnings track record?
Over the last 1 reported quarters with consensus data, 005690.KS beat estimates 1 times (100%).
What is 005690.KS's current P/E ratio and EPS?
005690.KS trades at a trailing P/E of 15.40 on trailing EPS of 726.285420305313 KRW.
What do analysts rate 005690.KS?
005690.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.